Figure 1.
Kaplan-Meier estimates of OS among chemotherapy as first-line and second-line AGC patients treated with paclitaxel, cisplatin and fluorouracil
Kaplan-Meier estimates of OS among chemotherapy as first-line and second-line AGC patients treated with paclitaxel, cisplatin and fluorouracil